IMCD stock: IMCD sets November 5 results date for IMCD stock

Published on 10/21/2026 at 16:27 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Goldman Sachs set a EUR 133.00 target on October 2, 2026. IMCD stock costs EUR 100.90 on October 21, 2026, below its EUR 105.55 high.

Analyst target and results

IMCD will publish first nine months 2026 results on November 5, 2026.
Goldman Sachs set a EUR 133.00 12-month target on October 2, 2026.
IMCD stock costs EUR 100.90 at Lang & Schwarz on October 21, 2026 at 4:11 p.m. CEST and sits 4.41 percent below its EUR 105.55 52-week high.

Geometrisches Bauhaus-Poster mit Chemiekolben, Pfeilen und dem Kürzel CHEM in Primärfarben — Bauhaus-Poster mit Sektor-Kürzel CHEM symbolisiert Geschäftsfeld von IMCD N.V., ISIN NL0010801007, geometrisch reduziert, Illustration mit AI erstellt.

IMCD (ISIN NL0010801007) will publish its first nine months 2026 results on November 5, 2026, according to IMCD. The company has set the release for 7:00 a.m. CET, followed by an analyst webcast at 9:00 a.m. CET. IMCD was trading at EUR 100.90 at Lang & Schwarz on October 21, 2026 at 4:11 p.m. CEST.

Goldman target leaves room

Goldman Sachs added IMCD to its October European Conviction List on October 2, 2026 and assigned a 12-month price target of EUR 133.00, according to CNBC. Relative to the Lang & Schwarz price of EUR 100.90, the target lies 31.81 percent above the stock price. Goldman linked its view to IMCD's specialty chemicals distribution model and its focus on higher-value ingredients.

Stock sits below yearly high

The EUR 100.90 quote is 4.41 percent below IMCD's 52-week high of EUR 105.55 and 48.10 percent above its 52-week low of EUR 68.14, both as of October 21, 2026. The market capitalization was EUR 6.0 billion, with a price-to-earnings ratio of 25.88 and a trading volume of 19,040 shares at the same market-data timestamp.

Results date and valuation

IMCD's investor-relations page lists revenue of EUR 4,778.9 million for fiscal year 2025, up 5.00 percent on a constant-currency basis. Gross profit reached EUR 1,193.5 million, up 3.00 percent on the same basis, while operating EBITA was EUR 497.8 million, down 3.00 percent. Free cash flow was EUR 465.2 million, compared with EUR 449.7 million in fiscal year 2024, according to IMCD.

The November 5 publication will provide the next interim view of revenue, operating EBITA and cash generation. The company describes its business as asset-light and operates across more than 60 countries with over 80 application laboratories, according to GlobeNewswire.

Price and investor calendar

For investors, the November results date and the EUR 133.00 Goldman Sachs target define the next checkpoints, while the current quote remains below its EUR 105.55 yearly high. The further course of trading is shown by the continuously updated real-time quote of IMCD stock.